|
DE2725148A1
(de)
|
1977-06-03 |
1978-12-14 |
Hoechst Ag |
1-aryl-4-alkyl-1,2,4-triazol-5-one und verfahren zu ihrer herstellung
|
|
US20050096360A1
(en)
|
2003-08-08 |
2005-05-05 |
Salter-Cid Luisa M. |
Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment of diseases
|
|
KR100572996B1
(ko)
|
2003-08-12 |
2006-04-25 |
한국화학연구원 |
불소화 비닐 에테르 측쇄기를 갖는 아졸계 살균제 화합물및 그의 제조방법
|
|
KR20060135781A
(ko)
|
2004-02-25 |
2006-12-29 |
라 졸라 파마슈티칼 컴파니 |
질병의 치료를 위한 아민 및 아미드
|
|
TW200726765A
(en)
|
2005-06-17 |
2007-07-16 |
Bristol Myers Squibb Co |
Triazolopyridine cannabinoid receptor 1 antagonists
|
|
WO2007120528A2
(en)
*
|
2006-03-31 |
2007-10-25 |
La Jolla Pharmaceutical Company |
Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases
|
|
WO2008118414A1
(en)
|
2007-03-28 |
2008-10-02 |
Merck & Co., Inc. |
Substituted pyrido[3,2-e][1,2,4]triazolo[4,3-c]pyrimidine derivatives as cannabinoid-1 receptor modulators
|
|
BRPI0809617A2
(pt)
|
2007-03-29 |
2014-09-16 |
Hoffmann La Roche |
Inibidores não-nucleosídicos da transcriptase reversa
|
|
GB0722075D0
(en)
|
2007-11-09 |
2007-12-19 |
Smithkline Beecham Corp |
Compounds
|
|
JP2011504485A
(ja)
|
2007-11-21 |
2011-02-10 |
ファーマクシス リミテッド |
Ｓｓａｏ／ｖａｐ−１のハロアリルアミン阻害剤およびその用途
|
|
WO2010096722A1
(en)
|
2009-02-20 |
2010-08-26 |
Takeda Pharmaceutical Company Limited |
3-oxo-2, 3-dihydro- [1,2, 4] triazolo [4, 3-a]pyridines as soluble epoxide hydrolase (seh) inhibitors
|
|
WO2013134562A1
(en)
*
|
2012-03-09 |
2013-09-12 |
Inception 2, Inc. |
Triazolone compounds and uses thereof
|
|
US9192617B2
(en)
|
2012-03-20 |
2015-11-24 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
|
EP3438087A1
(en)
|
2012-05-02 |
2019-02-06 |
Boehringer Ingelheim International GmbH |
Substituted 3-haloallylamine inhibitors of ssao and uses thereof
|
|
BR112015026631A2
(pt)
*
|
2013-04-25 |
2017-07-25 |
Yuhan Corp |
compostos ou sais farmaceuticamente aceitáveis dos mesmos e respectivos usos, composição farmacêutica e método para prevenir ou tratar diabetes melito em mamífero
|
|
WO2016007727A1
(en)
|
2014-07-10 |
2016-01-14 |
Incyte Corporation |
Triazolopyridines and triazolopyrazines as lsd1 inhibitors
|
|
EP3230277B1
(en)
|
2014-12-11 |
2019-09-18 |
Zenith Epigenetics Ltd. |
Substituted heterocycles as bromodomain inhibitors
|
|
WO2016101119A1
(en)
|
2014-12-23 |
2016-06-30 |
Merck Sharp & Dohme Corp. |
Fused heteroaryl derivatives as orexin receptor antagonists
|
|
TW201722958A
(zh)
*
|
2015-09-15 |
2017-07-01 |
葛蘭素史克智慧財產（第二）有限公司 |
化學化合物
|
|
JP6849197B2
(ja)
|
2016-02-12 |
2021-03-24 |
ファーマクシス リミテッド |
リジルオキシダーゼのインドールおよびアザインドールハロアリルアミン誘導体阻害剤およびその使用
|
|
WO2017191112A1
(en)
|
2016-05-03 |
2017-11-09 |
Bayer Pharma Aktiengesellschaft |
Fluoroalkyl-substituted aryltriazole derivatives and uses thereof
|
|
WO2018027892A1
(en)
|
2016-08-12 |
2018-02-15 |
Eli Lilly And Company |
Amino pyrimidine ssao inhibitors
|
|
BR112019005930A2
(pt)
|
2016-10-19 |
2019-06-11 |
Boehringer Ingelheim Int |
combinações compreendendo um inibidor de ssao/vap-1 e um inibidor de sglt2, e usos das mesmas
|
|
US20200069648A1
(en)
|
2017-03-02 |
2020-03-05 |
Pharmaxis Ltd. |
Haloallylamine pyrazole derivative inhibitors of lysyl oxidases and uses thereof
|
|
US20200087248A1
(en)
|
2017-04-28 |
2020-03-19 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Fluoroallylamine Derivative And Use Thereof
|
|
AU2018287777B2
(en)
|
2017-06-20 |
2020-05-21 |
Shandong Danhong Pharmaceutical Co., Ltd. |
SSAO inhibitor
|
|
CN109810041B
(zh)
|
2017-11-21 |
2023-08-15 |
药捷安康(南京)科技股份有限公司 |
卤代烯丙基胺类ssao/vap-1抑制剂及其应用
|
|
CN109988109B
(zh)
|
2017-12-29 |
2020-12-29 |
广东东阳光药业有限公司 |
抑制ssao/vap-1的胺类化合物及其用途
|
|
KR20190110740A
(ko)
|
2018-03-21 |
2019-10-01 |
주식회사유한양행 |
신규의 아릴 또는 헤테로아릴 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
|
|
KR20190110736A
(ko)
|
2018-03-21 |
2019-10-01 |
주식회사유한양행 |
신규의 트라이아졸론 유도체 또는 이의 염 및 이를 포함하는 약학 조성물
|
|
CN110938059A
(zh)
|
2018-09-25 |
2020-03-31 |
上海轶诺药业有限公司 |
胺基脲敏感性胺氧化酶抑制剂制备及其应用
|
|
WO2020063854A1
(zh)
|
2018-09-27 |
2020-04-02 |
南京明德新药研发有限公司 |
作为vap-1抑制剂的喹啉类衍生物
|
|
CN113164454A
(zh)
|
2018-09-28 |
2021-07-23 |
奥克塞拉有限公司 |
Vap-1的抑制剂
|
|
MX2021003731A
(es)
|
2018-09-28 |
2021-08-05 |
Acucela Inc |
Inhibidores de vap-1.
|
|
CN112789277B
(zh)
|
2018-10-22 |
2022-11-04 |
广东东阳光药业有限公司 |
胍类衍生物及其用途
|
|
AU2019365213A1
(en)
|
2018-10-24 |
2021-06-03 |
Metacrine, Inc. |
SSAO inhibitors and uses thereof
|
|
TWI835945B
(zh)
|
2018-12-14 |
2024-03-21 |
南韓商柳韓洋行股份有限公司 |
3,3-二氟烯丙胺化物或其鹽及包含彼的醫藥組合物
|
|
TW202039486A
(zh)
|
2018-12-14 |
2020-11-01 |
南韓商柳韓洋行股份有限公司 |
三唑并吡啶-3-酮化物或其鹽及包含彼之醫藥組合物
|
|
BR112021013429A2
(pt)
|
2019-01-11 |
2021-10-19 |
Nanjing Transthera Biosciences Co., Ltd. |
Composto, composição farmacêutica, e, uso do composto
|